Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Abstract

A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.

R L Cavanagh, J J Usakewicz and J P Buyniski
Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 171-179;
R L Cavanagh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J J Usakewicz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J P Buyniski
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 224 no. 1 171-179
PubMed 
6129316

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online January 1, 1983.


Author Information

  1. R L Cavanagh,
  2. J J Usakewicz and
  3. J P Buyniski

    Statistics from Altmetric.com

    Article usage

    Article usage: January 1999 to March 2021

    AbstractFullPdf
    Jan 1999100
    Feb 1999100
    Apr 1999100
    Jun 1999100
    Dec 1999100
    Jun 2000100
    Oct 2000200
    May 2001200
    Jul 2001100
    Aug 2001100
    Oct 2001100
    Nov 2001100
    Mar 2002100
    Aug 2002100
    Sep 2002200
    Oct 2002100
    May 2003100
    Jul 2003500
    Aug 2003900
    Sep 2003700
    Oct 2003800
    Nov 20031100
    Dec 2003300
    Jan 20041200
    Feb 2004700
    Mar 2004800
    Apr 2004600
    May 2004700
    Jun 20041200
    Jul 20041000
    Aug 2004700
    Sep 2004700
    Oct 20041300
    Nov 2004600
    Dec 2004600
    Jan 2005600
    Feb 2005900
    Mar 20051800
    Apr 2005500
    May 2005400
    Jun 20051100
    Jul 2005700
    Aug 2005200
    Sep 2005500
    Oct 20051100
    Nov 20051000
    Dec 2005600
    Jan 2006500
    Feb 2006400
    Mar 2006901
    Apr 2006500
    May 2006602
    Jun 2006301
    Aug 2006001
    Sep 2006400
    Oct 2006101
    Nov 2006404
    Jan 2007301
    Feb 20071202
    Mar 2007200
    Apr 2007200
    May 2007301
    Jun 2007200
    Jul 2007202
    Aug 2007804
    Sep 2007402
    Oct 2007100
    Nov 2007501
    Dec 2007100
    Jan 2008201
    Feb 2008200
    Mar 2008502
    Apr 2008200
    May 2008203
    Jun 2008202
    Jul 2008203
    Aug 2008300
    Sep 2008101
    Oct 2008601
    Nov 20081001
    Dec 2008200
    Jan 2009401
    Feb 2009103
    Mar 2009302
    Apr 2009300
    May 2009101
    Jun 2009300
    Jul 2009001
    Aug 2009204
    Sep 2009300
    Oct 2009701
    Nov 2009300
    Dec 2009600
    Jan 2010302
    Feb 2010300
    Mar 2010203
    Apr 2010502
    May 2010200
    Jun 2010303
    Jul 2010102
    Aug 2010600
    Sep 2010201
    Oct 2010302
    Nov 2010400
    Dec 2010600
    Jan 2011100
    Feb 2011200
    Mar 2011708
    Apr 2011402
    May 2011400
    Jun 2011301
    Jul 2011511
    Aug 2011301
    Sep 2011200
    Oct 2011200
    Nov 2011700
    Dec 2011704
    Jan 2012301
    Feb 2012200
    Mar 2012401
    Apr 2012200
    May 2012900
    Jun 2012501
    Jul 2012300
    Aug 2012400
    Sep 2012100
    Oct 2012002
    Nov 2012300
    Dec 2012203
    Jan 2013305
    Feb 2013300
    Mar 2013200
    Apr 2013600
    May 2013704
    Jun 2013505
    Jul 2013001
    Aug 2013201
    Sep 2013302
    Oct 2013202
    Nov 2013201
    Dec 2013101
    Jan 2014300
    Feb 2014300
    Mar 2014200
    Apr 2014200
    May 2014100
    Jun 2014201
    Oct 2014502
    Nov 2014101
    Dec 2014101
    Jan 2015401
    Feb 2015300
    Mar 2015200
    May 2015200
    Jun 2015101
    Jul 2015401
    Aug 20154400
    Sep 2015500
    Oct 2015101
    Nov 2015201
    Dec 2015500
    Jan 2016600
    Feb 20161100
    Mar 2016500
    Apr 2016300
    May 20162000
    Jun 2016601
    Jul 2016500
    Aug 2016200
    Sep 2016502
    Oct 20161002
    Nov 2016803
    Dec 2016501
    Jan 2017400
    Feb 20171000
    Mar 2017900
    Apr 2017200
    May 20171500
    Jun 20171000
    Jul 20171202
    Aug 20171707
    Sep 2017701
    Oct 2017600
    Nov 2017701
    Dec 20171300
    Feb 20181700
    Mar 20181100
    Apr 20181301
    May 2018700
    Jun 20181300
    Jul 20181000
    Aug 2018301
    Sep 2018501
    Oct 2018600
    Nov 2018600
    Dec 2018200
    Jan 20191405
    Feb 2019200
    Mar 2019200
    Apr 2019401
    May 2019300
    Jun 2019102
    Jul 2019501
    Sep 2019801
    Oct 2019600
    Nov 2019901
    Dec 20191400
    Jan 20201800
    Feb 2020700
    Mar 2020403
    May 2020800
    Jun 20201000
    Jul 2020200
    Aug 2020100
    Sep 20201200
    Oct 20203200
    Nov 2020501
    Dec 20201201
    Jan 2021900
    Feb 20211100
    Mar 20211300

    PreviousNext
    Back to top

    In this issue

    Journal of Pharmacology and Experimental Therapeutics
    Vol. 224, Issue 1
    1 Jan 1983
    • Table of Contents
    • Table of Contents (PDF)
    • Index by author
    • Back Matter (PDF)
    • Editorial Board (PDF)
    • Front Matter (PDF)
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
    (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Abstract

    A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.

    R L Cavanagh, J J Usakewicz and J P Buyniski
    Journal of Pharmacology and Experimental Therapeutics January 1, 1983, 224 (1) 171-179;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Abstract

    A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.

    R L Cavanagh, J J Usakewicz and J P Buyniski
    Journal of Pharmacology and Experimental Therapeutics January 1, 1983, 224 (1) 171-179;
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    Similar Articles

    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About JPET
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Drug Metabolism and Disposition
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-0103 (Online)

    Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics